Dry eye disease is a multifactorial disease characterized by a loss of homeostasis on the ocular surface. Patients with dry ...
A panelist discusses how the COAT trial demonstrated that twice-daily 0.09% cyclosporine improves multiple signs and symptoms of dry eye disease within 28 days, highlighting the value of early ...
Claims from 192,793 newly diagnosed dry eye disease patients showed prescription initiation in 12.4%, indicating substantial ...
The Nebraska Department of Economic Development (DED) has released the 2026-2027 Qualified Action Plan (QAP) for the Business Innovation Act (BIA), outlining how the DED will allocate funds and ...
There are some topics that are so central to the experiences of both doctors and patients that they deserve an annual ...
Aldeyra Therapeutics Inc. is making another run at U.S. FDA clearance for reproxalap in dry eye disease (DED) after nailing the primary endpoint in a phase III randomized, double-masked, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results